Patent 7968310 was granted and assigned to BioGeneriX AG on June, 2011 by the United States Patent and Trademark Office.
The present invention provides modified Campylobacter sialyltransferase proteins that exhibit enhanced expression as compared to its unmodified form. Nucleic acids that encode the sialyltransferase proteins are also included, as are methods to produce and use the sialyltransferase proteins.